Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biocon has signed a Memorandum of Understanding (MOU) with BiotecCorp to explore collaboration and potential investment opportunities in the Malaysian biotechnology industry.
Subscribe to our email newsletter
Biocon is in talks with BiotecCorp to manufacture Biopharmaceutical products and formulation, within Malaysia’s Nusajaya, Iskandar Malaysia, known as Bio-XCell Ecosystem. Biocon is also developing biotechnology infrastructure in the Bio-XCell project.
Biocon opines that the collaboration, while giving a conducive ecosystem to further its biopharmaceutical activities, will also enable the transfer of knowledge to Malaysia’s human capital, create employment and knowledge workers, and directly benefit the growth of local industry.
Kiran Mazumdar-Shaw, chairman and managing director of Biocon, said: “Biocon is keen to explore Malaysia as a destination for our expansion. Malaysia and the Bio-XCell Ecosystem in Iskandar Malaysia are attractive propositions. We are interested in learning how we can leverage this offering with our commercial plans and look forward to formalising our engagement with BiotehCorp further.”
Dota’ Iskandar Mizal Mahmood, CEO of BiotechCorp, said: “With the development of the Bio-XCell Ecosystem we are now able to offer a comprehensive support infrastructure, as well as the required supply of knowledge workers, favorable enviroment, and provision of related services.”